Literature DB >> 6040011

Outflow facility after guanethidine sulfate administration.

L Bonomi, P DiComite.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6040011     DOI： 10.1001/archopht.1967.00980030339014

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

1.  A double blind comparison of guanethidine-and-adrenaline drops with 1% adrenaline alone in chronic simple glaucoma.

Authors:  K B Mills; A E Ridgway
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

2.  Guanethidine and adrenaline used in combination in chronic simple glaucoma.

Authors:  J A Roth
Journal:  Br J Ophthalmol       Date:  1973-07       Impact factor: 4.638

3.  The combination of guanethidine 3% and adrenaline 0.5% in 1 eyedrop (GA) in glaucoma treatment.

Authors:  F J Hoyng; C L Dake
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

4.  A double-blind short-term trial of guanethidine 3% and adrenaline 0.5% combined in one eye drop.

Authors:  F J Hoyng; C L Dake; E L Greve
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-07-08

5.  Guanethidine--adrenaline eye drops in glaucoma simplex production and outflow of the aqueous humour during a long-term treatment.

Authors:  P F Hoyng; C L Dake
Journal:  Doc Ophthalmol       Date:  1980-10-15       Impact factor: 2.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.